Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

163
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
163
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

661
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
661
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

739
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
739
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

539
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
539
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

283
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
283

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concurrent comparison of severity of influenza and COVID-19 among hospitalized patients in Hong Kong: a target trial emulation on observational healthcare data.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Harnessing Large-Scale Multi-Omics Data for Risk Prediction and Deep Phenotyping of Valvular Heart Diseases in the General Population.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Prenatal Acetaminophen (Paracetamol) Use and the Risk of Autism and/or Attention-Deficit/Hyperactivity Disorder Among Sibling-Matched Cohorts.

JAMA internal medicine·2026
Same author

Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study.

PLoS medicine·2026
Same author

Identifying druggable proteins of the association of chronotype on breast cancer using Mendelian randomization.

Communications medicine·2026
Same author

A Target Trial Emulation to Investigate Kidney Protection from Statin Initiation in Adults with Normal Kidney Function.

Clinical journal of the American Society of Nephrology : CJASN·2026

Related Experiment Video

Updated: Jul 2, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

Evaluating different low-density lipoprotein cholesterol thresholds to initiate statin for prevention of

Eric Yuk Fai Wan1,2,3, Wanchun Xu1, Anna Hoi Ying Mok1

  • 1Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.

Diabetes, Obesity & Metabolism
|February 21, 2024
PubMed
Summary
This summary is machine-generated.

Initiating statin therapy for primary prevention of cardiovascular diseases (CVDs) in type 2 diabetes mellitus (T2DM) patients with lower baseline low-density lipoprotein cholesterol (LDL-C) levels (1.8-2.5 mmol/L) further reduces CVD and mortality risks. This approach is safe and effective, even for older adults, without increasing adverse events.

Keywords:
cardiovascular diseasehyperlipidaemiastatintype 2 diabetes mellitus

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.4K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.3K

Related Experiment Videos

Last Updated: Jul 2, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.4K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.3K

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Type 2 diabetes mellitus (T2DM) significantly increases cardiovascular disease (CVD) risk.
  • Statin therapy is a cornerstone for primary CVD prevention.
  • Optimal timing and baseline low-density lipoprotein cholesterol (LDL-C) thresholds for initiating statins in T2DM patients require further elucidation.

Purpose of the Study:

  • To evaluate the efficacy of initiating statin therapy at different baseline LDL-C levels for primary CVD prevention in T2DM patients.
  • To assess the safety profile of statin therapy across varying baseline LDL-C thresholds.

Main Methods:

  • Emulation of sequential trials using territory-wide electronic medical records in Hong Kong (2008-2014).
  • Inclusion of T2DM patients with elevated LDL-C levels.
  • Pooled logistic regression to determine hazard ratios for major CVDs, all-cause mortality, and adverse events (myopathies, liver dysfunction).

Main Results:

  • Statin initiation at LDL-C 1.8-2.5 mmol/L showed a hazard ratio of 0.78 (per-protocol) for CVD incidence, compared to 0.90 for LDL-C ≥2.6 mmol/L.
  • Absolute 10-year CVD risk reduction was greater with lower LDL-C thresholds (-7.1% vs. -3.9%).
  • No significant increase in adverse events (myopathies, liver dysfunction) was observed; effectiveness was consistent in patients >75 years.

Conclusions:

  • Initiating statin therapy at a lower LDL-C threshold (1.8-2.5 mmol/L) provides additional CVD and all-cause mortality risk reduction in T2DM patients.
  • This strategy is safe, with no significant increase in major adverse events.
  • The findings are applicable to elderly T2DM patients (>75 years).